NDC 52959-457 - Gabazolamine-0.5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-457
- Package NDCs from labels
- 52959-457-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabazolamine-0.5 | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-457-30 | Gabazolamine-0.5 | 30 in 1 BOTTLE | TABLET | 30 | 0.5 mg | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | Mylan Pharmaceuticals Inc. | 13930c94-d83a-414f-be35-b1fef35f738d | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 4d678da0-9ada-4d00-9db9-33b45c776107 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Ulai Health LLC | c0e27b02-8ef2-4239-8f8c-790f7d978dc0 | 2025-01-12 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 1541ff5b-11f8-444b-a2a0-8e3086ae650a | 2025-01-10 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | AvPAK | f31a4349-7826-45c0-9388-6b938d167b7a | 2025-01-09 | Warnings | F05Q2T2JA0 |
| Docusate sodium | DOCUSATE SODIUM | APNAR PHARMA LP | 05b0732b-012f-78ee-e063-6294a90a839a | 2025-01-09 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Safecor Health, LLC | efe4bf81-fb99-4755-aa23-4f8df5973be8 | 2025-01-08 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals,Inc. | 02840ea6-e4a0-96a0-e063-6394a90a19ae | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Senexon-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | NCS HealthCare of KY, LLC dba Vangard Labs | c049ef78-cc16-4209-b553-60cead5c9a80 | 2025-01-03 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 7538d0d0-346e-4c3e-8f7a-c1cac8ec8ed3 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 197322 YU55MQ3IZY |
| Laxative Docusate Sodium with Senna | DOCUSATE SODIUM AND SENNOSIDES | TOPCO ASSOCIATES LLC | cf9075d8-e20e-419a-b996-9b12f49f05f2 | 2025-01-01 | Warnings | F05Q2T2JA0 |
| Vegetable Laxative and Stool Softner | DOCUSATE SODIUM AND SENNOSIDES | TOPCO ASSOCIATES LLC | e84d693d-0041-4c11-8f6a-b5c332f79af9 | 2025-01-01 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | Advanced Rx of Tennessee, LLC | b39e2bc8-b68f-0f4e-e053-2995a90a00fd | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Advanced Rx of Tennessee, LLC | b4cd647f-1ba3-334e-e053-2995a90af352 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Advanced Rx of Tennessee, LLC | f667458d-ddda-4e9e-e053-2995a90adb5a | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | ANDA074112 308048 YU55MQ3IZY |
| Laxacin | DOCUSATE SODIUM AND SENNOSIDES | Advanced Rx Pharmacy of Tennessee, LLC | fe7d4d75-0f8a-1e7d-e053-6394a90afb4d | 2024-12-31 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | American Health Packaging | ea95d182-453b-4c43-8402-d65c488d55f2 | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | 308047 308048 YU55MQ3IZY |
| DOCUSATE SODIUM | DOCUSATE SODIUM | A-S Medication Solutions | 946abcdb-96bd-43e6-992a-bb97679c00f0 | 2024-12-30 | Warnings | F05Q2T2JA0 |
| GeriCare Docusate Sodium Liquid | DOCUSATE SODIUM | GERI-CARE PHARMACEUTICALS, CORP | e50558e1-f0c8-4b03-9109-6a273b61730d | 2024-12-20 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.